JP2014517825A5 - - Google Patents

Download PDF

Info

Publication number
JP2014517825A5
JP2014517825A5 JP2014506585A JP2014506585A JP2014517825A5 JP 2014517825 A5 JP2014517825 A5 JP 2014517825A5 JP 2014506585 A JP2014506585 A JP 2014506585A JP 2014506585 A JP2014506585 A JP 2014506585A JP 2014517825 A5 JP2014517825 A5 JP 2014517825A5
Authority
JP
Japan
Prior art keywords
use according
seconds
microprojection
contact
hpthrp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014506585A
Other languages
English (en)
Japanese (ja)
Other versions
JP6033280B2 (ja
JP2014517825A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/034510 external-priority patent/WO2012145665A2/en
Publication of JP2014517825A publication Critical patent/JP2014517825A/ja
Publication of JP2014517825A5 publication Critical patent/JP2014517825A5/ja
Application granted granted Critical
Publication of JP6033280B2 publication Critical patent/JP6033280B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014506585A 2011-04-22 2012-04-20 ＰＴＨ、ＰＴＨｒＰ、および関連ペプチドの薬剤送達方法 Expired - Fee Related JP6033280B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161478466P 2011-04-22 2011-04-22
US61/478,466 2011-04-22
US201161578120P 2011-12-20 2011-12-20
US61/578,120 2011-12-20
PCT/US2012/034510 WO2012145665A2 (en) 2011-04-22 2012-04-20 Method of drug delivery for pth, pthrp and related peptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016208896A Division JP2017036323A (ja) 2011-04-22 2016-10-25 ＰＴＨ、ＰＴＨｒＰ、および関連ペプチドの薬剤送達方法

Publications (3)

Publication Number Publication Date
JP2014517825A JP2014517825A (ja) 2014-07-24
JP2014517825A5 true JP2014517825A5 (cg-RX-API-DMAC7.html) 2015-06-11
JP6033280B2 JP6033280B2 (ja) 2016-11-30

Family

ID=47042187

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014506585A Expired - Fee Related JP6033280B2 (ja) 2011-04-22 2012-04-20 ＰＴＨ、ＰＴＨｒＰ、および関連ペプチドの薬剤送達方法
JP2016208896A Pending JP2017036323A (ja) 2011-04-22 2016-10-25 ＰＴＨ、ＰＴＨｒＰ、および関連ペプチドの薬剤送達方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016208896A Pending JP2017036323A (ja) 2011-04-22 2016-10-25 ＰＴＨ、ＰＴＨｒＰ、および関連ペプチドの薬剤送達方法

Country Status (14)

Country Link
US (6) US20130006217A1 (cg-RX-API-DMAC7.html)
EP (2) EP3332799A1 (cg-RX-API-DMAC7.html)
JP (2) JP6033280B2 (cg-RX-API-DMAC7.html)
KR (1) KR20140047043A (cg-RX-API-DMAC7.html)
CN (1) CN103917242A (cg-RX-API-DMAC7.html)
AU (2) AU2012245301B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013027153A2 (cg-RX-API-DMAC7.html)
CA (1) CA2833571A1 (cg-RX-API-DMAC7.html)
ES (1) ES2648864T3 (cg-RX-API-DMAC7.html)
IL (1) IL228942A0 (cg-RX-API-DMAC7.html)
MX (1) MX2013012349A (cg-RX-API-DMAC7.html)
RU (1) RU2013151314A (cg-RX-API-DMAC7.html)
SG (1) SG194570A1 (cg-RX-API-DMAC7.html)
WO (1) WO2012145665A2 (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012018486A2 (en) * 2010-07-26 2012-02-09 Seventh Sense Biosystems, Inc. Rapid delivery and/or receiving of fluids
EP3106159A1 (en) 2010-05-12 2016-12-21 Radius Health, Inc. Therapeutic regimens
AU2011312490B2 (en) 2010-09-28 2015-06-25 Radius Pharmaceuticals, Inc. Selective androgen receptor modulators
EP2637562B1 (en) 2010-11-09 2016-01-27 Seventh Sense Biosystems, Inc. Systems and interfaces for blood sampling
US9675675B2 (en) * 2011-11-30 2017-06-13 3M Innovative Properties Company Microneedle device having a peptide therapeutic agent and an amino acid, methods of making and using the same
CN104602752A (zh) * 2012-08-30 2015-05-06 帝人株式会社 涂布有药物组合物的微针阵列
FI3122426T3 (fi) 2014-03-28 2023-03-31 Univ Duke Rintasyövän hoitaminen käyttäen selektiivisiä estrogeenin reseptorin modulaattoreita
WO2016141250A1 (en) * 2015-03-03 2016-09-09 Radius Health, Inc. USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK
RU2747228C2 (ru) 2015-04-29 2021-04-29 Радиус Фармасьютикалз, Инк. Способы лечения рака
CN108025042A (zh) * 2015-07-06 2018-05-11 董正欣 PTHrP类似物的新型制剂
CN108135837B (zh) 2015-10-09 2022-05-31 3M创新有限公司 用于涂布微针阵列的锌组合物
AU2016334378B2 (en) * 2015-10-09 2021-12-02 Kindeva Drug Delivery L.P. Formulations of PTHrP analogues, transdermal patches thereof, and uses thereof
CA3020333A1 (en) * 2016-04-18 2017-10-26 Radius Health, Inc. Formulations of abaloparatide, transdermal patches thereof, and uses thereof
EP3474841B1 (en) 2016-06-22 2022-03-16 Ellipses Pharma Ltd Ar+ breast cancer treatment methods
JP7649624B2 (ja) * 2016-11-30 2025-03-21 パーデュー リサーチ ファウンデーション 副甲状腺ホルモン受容体刺激を介する、骨折をターゲティングした骨再生
LT3565542T (lt) 2017-01-05 2024-07-10 Radius Pharmaceuticals, Inc. Polimorfinės rad1901-2hcl formos
US9968767B1 (en) 2017-10-10 2018-05-15 King Saud University Combination microarray patch for drug delivery and electrochemotherapy device
WO2019232283A1 (en) 2018-05-30 2019-12-05 Purdue Research Foundation Targeting anabolic drugs for accelerated fracture repair
JP7473486B2 (ja) 2018-07-04 2024-04-23 ラジウス ファーマシューティカルズ，インコーポレイテッド Ｒａｄ１９０１－２ｈｃｌの多形形態
KR20210127961A (ko) 2019-02-12 2021-10-25 래디어스 파마슈티컬스, 인코포레이티드 방법 및 화합물
EP4110371A1 (en) 2020-01-24 2023-01-04 Radius Health, Inc. Methods of stimulating bone growth with abalopartide and denosumab
CN115734798A (zh) 2020-04-28 2023-03-03 提克纳有限责任公司 微针组件
US20230210762A1 (en) * 2020-05-01 2023-07-06 Emergex USA Corporation Transdermal drug delivery devices having psilocybin, lysergic acid diethylamide or 3,4-methylenedioxymethamphetamine coated microprotrusions
JP2024502334A (ja) * 2021-01-05 2024-01-18 ラジウス ヘルス，インコーポレイテッド アバロパラチドを用いた長骨骨折の治療
US12053284B2 (en) 2021-11-08 2024-08-06 Satio, Inc. Dermal patch for collecting a physiological sample
US11877848B2 (en) 2021-11-08 2024-01-23 Satio, Inc. Dermal patch for collecting a physiological sample
US12023156B2 (en) 2021-10-13 2024-07-02 Satio, Inc. Dermal patch for collecting a physiological sample
US11964121B2 (en) 2021-10-13 2024-04-23 Satio, Inc. Mono dose dermal patch for pharmaceutical delivery
US12178979B2 (en) 2021-10-13 2024-12-31 Satio, Inc. Dermal patch for delivering a pharmaceutical
US12048543B2 (en) 2021-11-08 2024-07-30 Satio, Inc. Dermal patch for collecting a physiological sample with removable vial
US12029562B2 (en) 2021-04-14 2024-07-09 Satio, Inc. Dermal patch system
US12214346B2 (en) 2021-10-13 2025-02-04 Satio, Inc. Dermal patch with a diagnostic test strip

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544949B1 (en) * 1995-07-13 2003-04-08 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Analogs of parathyroid hormone
US5969095A (en) 1995-07-13 1999-10-19 Biomeasure, Inc. Analogs of parathyroid hormone
EP1037686B1 (en) * 1997-12-11 2005-08-17 Alza Corporation Device for enhancing transdermal agent flux
CA2313458C (en) * 1997-12-11 2007-04-17 Alza Corporation Device for enhancing transdermal agent flux
US6091975A (en) * 1998-04-01 2000-07-18 Alza Corporation Minimally invasive detecting device
GB9930882D0 (en) * 1999-12-30 2000-02-23 Nps Allelix Corp GLP-2 formulations
JP2007535337A (ja) * 2003-10-28 2007-12-06 アルザ・コーポレーシヨン 被覆された微小突起による治療用ペプチドおよびタンパクのポリマー接合体の送達
BRPI0415629A (pt) 2003-10-31 2006-12-12 Alza Corp aplicador auto-atuador para conjunto de microprojeções
WO2005051456A2 (en) * 2003-11-13 2005-06-09 Alza Corporation Composition and apparatus for transdermal delivery
US7556821B2 (en) 2004-05-13 2009-07-07 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
US8057842B2 (en) 2004-11-18 2011-11-15 3M Innovative Properties Company Method of contact coating a microneedle array
WO2007084247A2 (en) * 2005-12-28 2007-07-26 Alza Corporation Stable therapeutic formulations
CA2680690A1 (en) * 2006-03-15 2007-09-20 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents to prevent or treat osteopenia
US9119945B2 (en) 2006-04-20 2015-09-01 3M Innovative Properties Company Device for applying a microneedle array
WO2007124409A2 (en) * 2006-04-20 2007-11-01 Velocys, Inc. Process for treating and/or forming a non-newtonian fluid using microchannel process technology
US7803770B2 (en) 2006-10-03 2010-09-28 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
AU2007322334B2 (en) 2006-10-03 2011-12-22 Ipsen Pharma S.A.S. Method of drug delivery for bone anabolic protein
ES2473620T3 (es) * 2007-02-06 2014-07-07 Hisamitsu Pharmaceutical Co., Inc. Dispositivo de microagujas para el diagnóstico de una alergia
ES2612061T3 (es) * 2007-09-28 2017-05-11 The Queen's University Of Belfast Dispositivo y método de suministro
US20090117158A1 (en) * 2007-10-23 2009-05-07 Mahmoud Ameri Transdermal sustained release drug delivery
EP2052736A1 (en) * 2007-10-26 2009-04-29 Nycomed Danmark ApS Parathyroid hormone formulations und uses thereof
ES2548378T3 (es) 2008-11-04 2015-10-16 Aska Pharmaceutical Co., Ltd. Composición acuosa que contiene hormona foliculoestimulante
US20110172609A1 (en) * 2010-01-08 2011-07-14 Ratio, Inc. Microneedle component assembly for drug delivery device

Similar Documents

Publication Publication Date Title
JP2014517825A5 (cg-RX-API-DMAC7.html)
Weinstein Glucocorticoid‐induced bone disease
Wakabayashi et al. Comprehensive approach to sarcopenia treatment
JP6033280B2 (ja) ＰＴＨ、ＰＴＨｒＰ、および関連ペプチドの薬剤送達方法
Fitzpatrick et al. The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral density
AU2012245301A1 (en) Method of drug delivery for PTH, PTHrP and related peptides
JP2014530242A (ja) 皮膚疾病の処置用のケメリンｃ１５ペプチドの局所製剤
Ahmed et al. Effect of 1.5% topical diclofenac on clinical neuropathic pain
Piscitelli et al. Alendronate: new formulations of an old and effective drug to improve adherence avoiding upper gastrointestinal side effects.
ME02644B (me) Novi preparati alfentanila za tretman akutnog bola
Bukata et al. Short-term and long-term orthopaedic issues in patients with fragility fractures
Avioli Calcitonin therapy in osteoporotic syndromes
Mazziotti et al. Treatment of glucocorticoid-induced osteoporosis
ES2425095T3 (es) Método de tratamiento de la fragilidad
RU2637401C1 (ru) Способ профилактики отдаленных послеоперационных осложнений у больных с дисплазией соединительной ткани
Sadigursky et al. Effectiveness of lidocaine patches for pain treatment after total knee arthroplasty
US20230330191A1 (en) Methods of stimulating bone growth with abaloparatide and denosumab
Park et al. Fixation of the femoral subtrochanteric fracture with minimally invasive reduction techniques
Jarusriwanna et al. A randomized trial comparing efficacy and safety of brand versus generic alendronate for osteoporosis treatment
Wang et al. Effect of anti-osteoporotic drugs in reducing risk of refracture after percutaneous vertebroplasty
Khuangsirikul et al. Effect of Transdermal Microneedle Patch with NSAID in Osteoarthritic Knee: A Randomized Controlled Trial
Hao et al. Effects Of Beta-hydroxy-beta-methylbutyrate On Markers Of Muscle Hypertrophy And Apoptotic Signaling During Reloading In Aged Rats Following Disuse: 592: June 2 10: 30 AM-10: 45 AM
Seeman et al. Zoledronic Acid Substantially Reduces the Risk of Morphometric Vertebral and Clinical Fractures
Lee Bone health in the treatment of postmenopausal women with Aromatase Inhibitors and premenopausal women treated with ovarian suppression and Aromatase inhibitors: a hands-on guide
Black et al. Effect of Once-Yearly Zoledronic Acid 5 Mg on A Sub-Set of Six Non-Vertebral Fractures